Other Income & Expense
Other Income (Expense)
Roivant Sciences Other Income (Expense) increased by 50.7% to $12.57M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 542.1%, from -$2.84M to $12.57M. Over 4 years (FY 2021 to FY 2025), Other Income (Expense) shows an upward trend with a 5.5% CAGR.
Analysis
StatementIncome Statement
SectionOther Income & Expense
CategoryProfitability
SignalContext dependent
VolatilityModerate
First reportedQ1 2014
Last reportedQ1 2026
How to read this metric
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Detailed definition
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Peer comparison
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
Metric ID:
other_income_expense_netHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $134.00K | -$3.69M | $1.03M | $5.77M | -$1.09M | -$5.95M | $18.10M | -$11.55M | $4.59M | -$1.53M | $2.11M | -$11.32M | -$3.61M | -$1.45M | -$2.82M | -$2.84M | -$11.21M | -$5.69M | $8.34M | $12.57M |
| QoQ Change | — | <-999% | +127.9% | +460.3% | -118.8% | -448.4% | +404.1% | -163.8% | +139.8% | -133.3% | +238.0% | -635.8% | +68.1% | +59.7% | -93.8% | -1.0% | -294.1% | +49.2% | +246.5% | +50.7% |
| YoY Change | — | — | — | — | -909.7% | -61.2% | >999% | -300.2% | +523.3% | +74.3% | -88.3% | +2.0% | -178.6% | +5.0% | -233.3% | +74.9% | -210.6% | -291.9% | +396.2% | +542.1% |
Range-$11.55M – $18.10M
CAGR+160.1%
Avg YoY Growth+62.7%
Median YoY Growth-29.6%
Current Streak3 quarters growth
Business Segments
| Segment | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|
| Reportable Segment | -$5.69M | $8.34M | $12.57M |
| Total | -$5.69M | $8.34M | $12.57M |
Other Income (Expense) at Other Companies
Frequently Asked Questions
- What is Roivant Sciences's other income (expense)?
- Roivant Sciences (ROIV) reported other income (expense) of $12.57M in Q1 2026.
- How has Roivant Sciences's other income (expense) changed year-over-year?
- Roivant Sciences's other income (expense) increased by 542.1% year-over-year, from -$2.84M to $12.57M.
- What is the long-term trend for Roivant Sciences's other income (expense)?
- Over 4 years (2021 to 2025), Roivant Sciences's other income (expense) has grown at a 5.5% compound annual growth rate (CAGR), from $3.24M to $4.01M.
- What does other income (expense) mean?
- The net result of all income and expenses not related to core business operations.